The Department of Pharmacy Services at Children’s Hospital of Philadelphia facilitates two Pharmacy Residency Programs: a one-year post graduate year 1 (PGY1) Pharmacy Residency Program and a one-year post-graduate year 2 (PGY2) Pediatric Pharmacy Residency Program.
The CHOP PGY1 Pharmacy Residency Program builds on Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training. It is a one-year (52 weeks) training program that begins at the end of June/beginning of July and runs through June 30th of the following year. The residency program is accredited by the American Society of Health-System Pharmacists (ASHP) and is is designed to foster clinical competency in pharmacotherapeutics, an understanding of the practical and administrative considerations of providing pharmaceutical care and an introduction to clinical research. The resident will function as an active member of various multidisciplinary medical teams. They will be able to tailor the learning experiences to best meet their professional goals. A Certificate for completion of the PGY1 Pharmacy Residency Program will be conferred to the resident at the completion of the program requirements.
The purpose of the PGY2 Pediatric Pharmacy Residency at Children's Hospital of Philadelphia is to build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in pediatrics. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification (BCPPS). It is a one-year (52 weeks) training program lasting from the first week in July through June 30th of the following year. The residency program is accredited by the American Society of Health-System Pharmacists (ASHP) and is designed to foster clinical expertise in pediatric pharmacotherapeutics, an understanding of the practical and administrative considerations of providing pharmaceutical care to pediatric patients and experience in teaching as well as clinical research. The resident will function as an active member of various multidisciplinary pediatric teams. They will be able to tailor learning experiences to best meet their professional goals. The residency program consists of approximately eight months of required learning experiences and four months of elective learning experiences. A Certificate for completion of the PGY2 Pediatric Pharmacy Residency Program will be conferred to the resident upon the successful completion of the program requirements.
Children's Hospital of Philadelphia (CHOP) is the nation's first hospital devoted exclusively to the care of children. Since our start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives. Today, families facing complex conditions come to CHOP from all over the world, and our compassionate care and innovation has repeatedly earned us a spot on the U.S. News & World Report's Honor Roll of the nation's best children's hospitals.